NASDAQ: NPCE - NeuroPace, Inc.

Altı ay boyunca karlılık: +70.01%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı NeuroPace, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.

daha fazla ayrıntı
The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2021-04-22
ISIN US6412881053
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.neuropace.com
Цена ао 12.72
Günlük fiyat değişimi: -4.28% (12.38)
Haftalık fiyat değişimi: -1.41% (12.02)
Aylık fiyat değişimi: -12.09% (13.48)
3 ayda fiyat değişimi: +11.06% (10.67)
Altı ayda fiyat değişimi: +70.01% (6.97)
Yıllık fiyat değişimi: -10.23% (13.2)
3 yılda fiyat değişimi: +41.92% (8.35)
Yılbaşından bu yana fiyat değişimi: +6.37% (11.14)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 4.08 4
P/BV 40.67 1
P/E 0 0
EV/EBITDA -17.8 0
Toplam: 3.38

Yeterlik

İsim Anlam Seviye
ROA, % -30.61 0
ROE, % -159.56 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -3.38 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 94.42 9
karlılık Ebitda, % 73.37 8
karlılık EPS, % -65.26 0
Toplam: 3.4
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
KCK Limited 5621111 21.39
Orbimed Advisors LLC. 4003967 15.23
Morgan Stanley 2460716 9.36
Soleus Capital Management, L.P. 2433168 9.26
Nantahala Capital Management, LLC 2347354 8.93
Kent Lake Capital, LLC 670946 2.55
FMR, LLC 468081 1.78
Vanguard Group Inc 413106 1.57
Millennium Management LLC 172403 0.66
Geode Capital Management, LLC 115996 0.44

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
iShares Micro-Cap ETF 0.02573 17.09 1.54048
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
iShares Russell 2000 Growth ETF 0.00726 38.04 0.6026
ProShares UltraPro Russell2000 0.0022 89.82 1.47873
ProShares Hedge Replication ETF 0.00058 5.92 1.47892
Vanguard Russell 2000 ETF 0 17.16 1.48801
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.0131.851.23



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Martha J. Morrell Chief Medical Officer 728.68k 1957 (68 yıllar)
Mr. Joel D. Becker CEO, President & Director 762k 1968 (57 yıllar)
Ms. Rebecca L. Kuhn CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary 614.91k 1961 (64 yıl)
Ms. Kelley Nicholas Vice President of Sales N/A
Ms. Leah Akin Acting General Counsel N/A
Mr. Dylan St. John Chief of Operations & Development

Adres: United States, Mountain View. CA, 455 North Bernardo Avenue - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.neuropace.com